Boston Partners Biogen Inc. Transaction History

Boston Partners

$80.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $60.8 Million - $76.6 Million	-313,782 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $4.21 Million - $5.41 Million	-18,807 Reduced 5.65%	313,782 $75.3 Million
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $3.26 Million - $4.25 Million	11,506 Added 3.58%	332,589 $94.1 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $3.9 Million - $6.24 Million	15,047 Added 4.92%	321,083 $111 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $3.21 Million - $3.76 Million	13,221 Added 4.52%	306,036 $85.6 Million
Q4 2020 Feb 04, 2021	BUY	$236.26 - $355.63 $224,447 - $337,848	950 Added 0.33%	292,815 $71.7 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $3.42 Million - $3.95 Million	-12,909 Reduced 4.24%	291,865 $82.8 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $8.96 Million - $11.9 Million	-34,640 Reduced 10.21%	304,774 $81.5 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $285 Million - $362 Million	-1,061,842 Reduced 75.78%	339,414 $107 Million
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $24.5 Million - $33.8 Million	-111,192 Reduced 7.35%	1,401,256 $416 Million
Q3 2019 Nov 20, 2019	SELL	$217.44 - $243.88 $12.6 Million - $14.1 Million	-57,749 Reduced 3.68%	1,512,448 $353 Million
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $73,494 - $82,431	338 Added 0.02%	1,570,197 $368 Million
Q2 2019 Aug 26, 2019	SELL	$219.29 - $241.72 $16,666 - $18,370	-76 Reduced -0.0%	1,569,859 $367 Million
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $142 Million - $156 Million	647,217 Added 70.14%	1,569,935 $367 Million
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $162 Million - $253 Million	746,711 Added 424.25%	922,718 $218 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $1.09 Million - $1.38 Million	3,920 Added 2.28%	176,007 $53 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $26.4 Million - $34.6 Million	-90,040 Reduced 34.35%	172,087 $60.8 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $67.5 Million - $80.4 Million	262,127 New	262,127 $76.1 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account